Skip to main content
Equibles

Tower Research Capital LLC (TRC)

Position in ANRO — Alto Neuroscience, Inc.

CIK 1533421 NEW YORK, NY
Back to ANRO Full portfolio

Position in ANRO

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$52,673
+$51,212 QoQ
Shares Held
1,996
+2970.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#93
of 114 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANRO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,739,988 across 466 Biotechnology names. ANRO ranks #133 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 4,547 $4,218,570
2 BBIO
BridgeBio Pharma, Inc.
 38,206 $2,845,582
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 34,537 $2,815,110
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,292 $2,131,964
5 MDGL
Madrigal Pharmaceuticals, Inc.
 3,927 $2,108,602
6 AXSM
Axsome Therapeutics, Inc.
 6,437 $1,575,584
7 INSM
INSMED Inc
 10,927 $1,165,036
8 ROIV
Roivant Sciences Ltd.
 32,746 $1,158,880

All Filings in ANRO

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $52,673 1,996
2026-03-31 $1,461 65
2025-12-31 $35,368 1,987
2025-09-30 $9,607 2,390
2025-06-30 $5,759 2,618
2025-03-31 $9,151 4,237
2024-12-31 $11,386 2,692
2024-09-30 $14,048 1,228
2024-03-31 $16,056 1,046